Rehmann Capital Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$214K Sell
1,694
-296
-15% -$37.4K 0.01% 566
2025
Q1
$255K Buy
1,990
+1
+0.1% +$128 0.02% 524
2024
Q4
$263K Sell
1,989
-473
-19% -$62.6K 0.02% 507
2024
Q3
$359K Sell
2,462
-66
-3% -$9.61K 0.02% 419
2024
Q2
$347K Buy
+2,528
New +$347K 0.02% 412
2022
Q1
Sell
-2,207
Closed -$337K 553
2021
Q4
$337K Sell
2,207
-61
-3% -$9.31K 0.03% 411
2021
Q3
$367K Sell
2,268
-2,757
-55% -$446K 0.03% 390
2021
Q2
$828K Buy
5,025
+2,168
+76% +$357K 0.08% 215
2021
Q1
$430K Buy
2,857
+62
+2% +$9.34K 0.04% 325
2020
Q4
$423K Buy
2,795
+593
+27% +$89.8K 0.05% 302
2020
Q3
$298K Buy
2,202
+31
+1% +$4.2K 0.04% 325
2020
Q2
$297K Buy
+2,171
New +$297K 0.04% 323
2019
Q3
Sell
-2,450
Closed -$267K 1860
2019
Q2
$267K Buy
2,450
+970
+66% +$106K 0.03% 377
2019
Q1
$166K Buy
1,480
+602
+69% +$67.3K 0.02% 456
2018
Q4
$84.7K Sell
878
-988
-53% -$95.3K 0.01% 446
2018
Q3
$228K Sell
1,866
-332
-15% -$40.5K 0.03% 370
2018
Q2
$241K Buy
2,198
+353
+19% +$38.8K 0.04% 328
2018
Q1
$197K Buy
+1,845
New +$197K 0.03% 371
2017
Q2
Sell
-2,451
Closed -$240K 393
2017
Q1
$240K Sell
2,451
-102
-4% -$9.99K 0.04% 330
2016
Q4
$226K Buy
+2,553
New +$226K 0.04% 342
2015
Q3
Sell
-1,788
Closed -$220K 351
2015
Q2
$220K Sell
1,788
-567
-24% -$69.8K 0.05% 293
2015
Q1
$269K Buy
2,355
+138
+6% +$15.8K 0.06% 254
2014
Q4
$224K Sell
2,217
-534
-19% -$54K 0.05% 294
2014
Q3
$251K Sell
2,751
-96
-3% -$8.76K 0.06% 266
2014
Q2
$244K Buy
+2,847
New +$244K 0.06% 275
2014
Q1
Sell
-2,784
Closed -$211K 332
2013
Q4
$211K Sell
2,784
-1,212
-30% -$91.9K 0.06% 271
2013
Q3
$279K Buy
+3,996
New +$279K 0.09% 199